Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review

March 2021 | 40 pages | ID: GE6979E7669EN
GlobalData

Abstracts

Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing other indications. The Genedrive HCVID test is the company’s CE-IVD certified molecular diagnostics platform which also finds application in genotyping or patient stratification. The company sells Genedrive HCVID test through distribution agreement with Arkray Healthcare pvt Ltd in India, and through subsidiaries of Sysmex Corp in Europe, the Middle East and Africa and South East Asia excluding India. The company is also advancing molecular diagnostic tests for antibiotic induced hearing loss and tuberculosis. Genedrive is headquartered in Manchester, the UK.

Genedrive Plc Key Recent Developments

Apr 21,2020: Genedrive and Cytiva to develop PCR assay for coronavirus
Mar 25,2020: genedrive: Business Update and Rapid Development of Coronavirus (SARS-COV-2) tests Plan for high throughput SARS-COV-2 test to be available in 8 weeks
Feb 04,2020: genedrive: Half Year Report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Genedrive Plc - Key Facts
Genedrive Plc - Key Employees
Genedrive Plc - Key Employee Biographies
Genedrive Plc - Major Products and Services
Genedrive Plc - History
Genedrive Plc - Company Statement
Genedrive Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Genedrive Plc - Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
Geographical Segment: UK
Performance
R&D Overview
Genedrive Plc - Corporate Strategy
Genedrive Plc - SWOT Analysis
SWOT Analysis - Overview
Genedrive Plc - Strengths
Genedrive Plc - Weaknesses
Genedrive Plc - Opportunities
Genedrive Plc - Threats
Genedrive Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genedrive Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genedrive Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genedrive Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 21, 2020: Genedrive and Cytiva to develop PCR assay for coronavirus
Mar 25, 2020: genedrive: Business Update and Rapid Development of Coronavirus (SARS-COV-2) tests Plan for high throughput SARS-COV-2 test to be available in 8 weeks
Feb 04, 2020: genedrive: Half Year Report

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Genedrive Plc, Key Facts
Genedrive Plc, Key Employees
Genedrive Plc, Key Employee Biographies
Genedrive Plc, Major Products and Services
Genedrive Plc, History
Genedrive Plc, Subsidiaries
Genedrive Plc, Key Competitors
Genedrive Plc, Ratios based on current share price
Genedrive Plc, Annual Ratios
Genedrive Plc, Annual Ratios (Cont...1)
Genedrive Plc, Interim Ratios
Genedrive Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genedrive Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genedrive Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Genedrive Plc, Performance Chart (2016 - 2020)
Genedrive Plc, Ratio Charts
Genedrive Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genedrive Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021